Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome

被引:0
作者
Zhihao Zhang
Yanli Hong
Minmin Chen
Ninghua Tan
Shijia Liu
Xiaowei Nie
Wei Zhou
机构
[1] China Pharmaceutical University,State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy
[2] Affiliated Hospital of Nanjing University of Chinese Medicine,School of Traditional Chinese Pharmacy
[3] China Pharmaceutical University,Department of Reproductive Center
[4] Affiliated Hospital of Nanjing University of Chinese Medicine,Department of Clinical Pharmacology
[5] Affiliated Hospital of Nanjing University of Chinese Medicine,undefined
来源
Metabolomics | 2020年 / 16卷
关键词
Polycystic ovary syndrome; Metabolomics; Biomarkers; Hyperandrogenism; Insulin resistance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 105 条
[1]  
Allison D(2017)Global metabolomics Nature Methods 14 32-2855
[2]  
Bozdag G(2016)The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis Human Reproduction 31 2841-184
[3]  
Mumusoglu S(2019)Identification of the metabolic fingerprints in women with polycystic ovary syndrome using the multiplatform metabolomics technique Journal of Steroid Biochemistry and Molecular Biology 186 176-655
[4]  
Zengin D(2015)PCOS in adolescence and type 2 diabetes Current Diabetes Reports 15 564-34
[5]  
Karabulut E(2016)Genetic, hormonal and metabolic aspects of PCOS: An update Reproductive Biology and Endocrinology 14 38-785
[6]  
Yildiz BO(1997)Reduced plasma concentrations of alpha-tocopherol and beta-carotene in obese boys The Journal of Pediatrics 130 653-1009
[7]  
Buszewska-Forajta M(2006)Polycystic ovary syndrome: The influence of environmental and genetic factors Hormones 5 17-782
[8]  
Rachoń D(2013)Cancer risk and PCOS Steroids 78 782-297
[9]  
Stefaniak A(2012)Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: Plasma metabolomic approach using GC–MS Clinical Chemistry 58 999-988
[10]  
Wawrzyniak R(2017)Women with polycystic ovary syndrome demonstrate worsening markers of cardiovascular risk over the short-term despite declining hyperandrogenaemia: Results of a longitudinal study with community controls Clinical Endocrinology 87 775-326